Active TB Rapid Test

LIODetect® TB-ST

LIONEX has special interest in developing a TB Rapid test for TB endemic countries. Our research of the past 18 years has helped us in developing an active TB rapid test showing high specificity of ca. 98% at an overall sensitivity of 65%. Our latest Rapid test called LIODetect^®TBST has a cocktail of five, highly purified recombinant proteins as well as a native surface antigen of M. tuberculosis coated as a separate line. In an independent evaluation in RUSSIA, this new TB Rapid test has shown much higher sensitivities in Russia, which are in the range as suggested by the Words Health Organisation (WHO). Large scale clinical studies are now in progress in a number of African and Asian countries.